LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.41 | 84.90 | 7237 | 8766 | 0.8255 | 0.9435 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.41 | 84.90 | 8044 | 8766 | 0.9176 | 0.9745 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.41 | 84.90 | 8324 | 8766 | 0.9495 | 0.9846 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.41 | 84.90 | 865 | 8766 | 0.0987 | 0.4148 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.41 | 84.90 | 8580 | 8766 | 0.9787 | 0.9936 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.41 | 84.90 | 812 | 8766 | 0.0926 | 0.4015 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 67.41 | 84.90 | 9126 | 8766 | 1.0410 | 1.0121 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.11 | 84.90 | 7232 | 8988 | 0.8046 | 0.9364 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.11 | 84.90 | 7367 | 8988 | 0.8197 | 0.9417 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.11 | 84.90 | 7946 | 8988 | 0.8841 | 0.9637 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.11 | 84.90 | 8439 | 8988 | 0.9389 | 0.9814 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.11 | 84.90 | 712 | 8988 | 0.0792 | 0.3719 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.11 | 84.90 | 8854 | 8988 | 0.9851 | 0.9955 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.11 | 84.90 | 805 | 8988 | 0.0896 | 0.3971 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 69.11 | 84.90 | 9342 | 8988 | 1.0394 | 1.0115 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 70.81 | 84.90 | 7259 | 9132 | 0.7949 | 0.9331 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 70.81 | 84.90 | 7494 | 9132 | 0.8206 | 0.9423 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 70.81 | 84.90 | 7091 | 9132 | 0.7765 | 0.9264 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 70.81 | 84.90 | 8493 | 9132 | 0.9300 | 0.9786 | MN20160318_Q02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 70.81 | 84.90 | 875 | 9132 | 0.0958 | 0.4129 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 70.81 | 84.90 | 9112 | 9132 | 0.9978 | 0.9994 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 70.81 | 84.90 | 862 | 9132 | 0.0944 | 0.4098 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 70.81 | 84.90 | 9525 | 9132 | 1.0430 | 1.0125 | MN20160318_Q02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 72.52 | 84.90 | 7382 | 9214 | 0.8011 | 0.9355 | MN20160318_Q02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 72.52 | 84.90 | 7598 | 9214 | 0.8246 | 0.9438 | MN20160318_Q02 | D03 |